Canada invests in radiopharmaceuticals
The Canadian government has invested more than $911,000 to support medical and pharmaceutical research at Canada's National Laboratory for Particle and Nuclear Physics--TRIUMF--through the Western Diversification Program.

The funding will support TRIUMF in upgrading infrastructure and in the acquisition of equipment which creates positron emission radiopharmaceuticals used during PET scanning. The upgraded equipment will ensure the facility has continued compliance with industry standards, added TRIUMF. 

TRIUMF is Canada’s national laboratory for particle and nuclear physics located on the University of British Columbia campus in Vancouver, British Columbia. It is owned and operated by a consortium of 15 Canadian universities.